With 25 years’ experience in the biopharmaceutical industry, CPC proudly engineers single-use connection technologies that address biopharmaceutical manufacturers’ requirements for reliability, assurance of sterility, and ease of use.

CPC’s innovative line of genderless AseptiQuik sterile connectors allows manufacturers to make quick and easy sterile connections, even in nonclassified environments. All genderless AseptiQuik connectors feature an easy-to-use three-step process that greatly minimizes the risk of operator error and ensures that sterility will be maintained both before and after connection.

Fill out the form below to read the complete technology review now.